CAROLYN LEGASPI: Open Payments
NPI 1396212049 · WEST HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $524 · 2025 $742
Food & beverage: $492Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $250 |
| Boston Scientific Corporation | 2 | $185 |
| Madrigal Pharmaceuticals | 2 | $173 |
| Gilead Sciences, Inc. | 1 | $135 |
Products named: TheraSphere Y90 Glass Microspheres 10 GBq, REZDIFFRA, Livdelzi.
Industry payments across CA — which companies pay providers there.
